Literature DB >> 2752835

Pleural effusion as the initial manifestation of disseminated cryptococcosis in acquired immune deficiency syndrome. Diagnosis by pleural biopsy.

A S Katz1, L Niesenbaum, B Mass.   

Abstract

Pleural effusion is an unusual presentation of cryptococcal infection in the acquired immune deficiency syndrome. Previous investigators have established the diagnosis of cryptococcal pleural disease by culturing pleural fluid, bronchial washings, and extrapulmonary sources. We report the first case of cryptococcal pleural effusion proved by closed pleural biopsy. Pleural biopsy may be an effective and rapid method of determining the etiology of pleural effusion in the acquired immune deficiency syndrome.

Entities:  

Mesh:

Year:  1989        PMID: 2752835     DOI: 10.1378/chest.96.2.440

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Cryptococcal pleural effusion as first indicator of AIDS: a case report.

Authors:  F de Lalla; A Vaglia; M Franzetti; V Manfrin; G P Pellizzer; P Fabris
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

Review 2.  Cryptococcus neoformans empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature.

Authors:  Christopher David Swan; Thomas Gottlieb
Journal:  BMJ Case Rep       Date:  2018-07-18

Review 3.  Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.

Authors:  Mayun Chen; Xiaomi Wang; Xianjuan Yu; Caijun Dai; Dunshun Chen; Chang Yu; Xiaomei Xu; Dan Yao; Li Yang; Yuping Li; Liangxing Wang; Xiaoying Huang
Journal:  BMC Infect Dis       Date:  2015-09-22       Impact factor: 3.090

4.  Cryptococcal Pleuritis Presenting with Lymphocyte-predominant and High Levels of Adenosine Deaminase in Pleural Effusions Coincident with Pulmonary Tuberculosis.

Authors:  Yoshitomo Kushima; Hidenori Takizawa; Yasutaka Machida; Takafumi Umetsu; Naoya Ikeda; Masaaki Miyoshi; Kazuyuki Chibana; Yasuo Shimizu; Akihiro Takemasa; Yoshiki Ishii
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.